Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness
Open Access
- 9 June 2001
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 93 (2) , 236-242
- https://doi.org/10.1002/ijc.1328
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Regulation of Tumor Growth and Metastasis by Interleukin-10: The Melanoma ExperienceJournal of Interferon & Cytokine Research, 1999
- Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsNature Medicine, 1999
- Tumor ImmunologyImmunity, 1998
- Elevated plasma levels of transforming growth factor (TGF)-β1 and TGF-β2 in patients with disseminated malignant melanomaBritish Journal of Cancer, 1998
- Activation or frustration of anti-tumor responses by T-cell-based immune modulationSeminars in Immunology, 1997
- Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 moleculesInternational Journal of Cancer, 1997
- Active specific immunotherapy with hapten-modified autologous melanoma cell vaccineCancer Immunology, Immunotherapy, 1996
- Is cancer dangerous to the immune system?Seminars in Immunology, 1996
- Expression of interleukin 10 in human melanomaBritish Journal of Cancer, 1994
- Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expressionInternational Journal of Cancer, 1993